TRV GP IV, LLC
CIK 1688325 · last filed 2025-10-27
TRV GP IV, LLC is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $14.5M of TNGX on Oct 27, 2025. Across all open-market trades the lifetime net is −$94.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $414.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$414.18M
2
10
-$94.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNGX | 10%+ Owner | 13,386,574 | $30.94 | $414.18M | -$85.23M | 8 | 2025-10-27 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | 10%+ Owner | 4,558,204 | $11.19 | $51.02M | -$9.17M | 2 | 2023-02-09 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-27 | TNGX | Sell (S) | −1,432,203 | -$14.54M | EDGAR |
| 2025-09-29 | TNGX | Sell (S) | −1,500,000 | -$12.03M | EDGAR |
| 2025-09-09 | TNGX | Sell (S) | −2,188,095 | -$15.33M | EDGAR |
| 2025-08-26 | TNGX | Sell (S) | −906,582 | -$6.35M | EDGAR |
| 2025-08-21 | TNGX | Sell (S) | −3,300,000 | -$23.14M | EDGAR |
| 2024-09-17 | TNGX | Sell (S) | −202,200 | -$2.13M | EDGAR |
| 2024-09-04 | TNGX | Sell (S) | −525,000 | -$6.09M | EDGAR |
| 2024-07-22 | TNGX | Sell (S) | −574,470 | -$5.64M | EDGAR |
| 2023-02-09 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Sell (S) | −11,100,000 | -$9.17M | EDGAR |
| 2021-08-26 | Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | Other (J) | −3,750,000 | $0 | EDGAR |